George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNovacyt Regulatory News (NCYT)

Share Price Information for Novacyt (NCYT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.25
Bid: 43.05
Ask: 45.45
Change: 0.00 (0.00%)
Spread: 2.40 (5.575%)
Open: 44.25
High: 0.00
Low: 0.00
Prev. Close: 44.25
NCYT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Adviser

2 Aug 2019 14:00

RNS Number : 7734H
Novacyt S.A.
02 August 2019
 

 

Novacyt S.A.

 

("Novacyt", the "Company" or the "Group")

 

Change of Adviser

 

Paris, France and Camberley, UK - 2 August 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that SP Angel Corporate Finance LLP will be the sole broker to the Company with immediate effect.

 

- End -

 

For further information, please refer to www.novacyt.com or contact:

 

Novacyt SA

Graham Mullis, Chief Executive Officer

Anthony Dyer, Chief Financial Officer

+44 (0)1223 395472

 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

Matthew Johnson / Jamie Spotswood (Corporate Finance)

Vadim Alexandre / Rob Rees (Corporate Broking)

+44 (0)20 3470 0470

 

FTI Consulting (International)

Brett Pollard / Victoria Foster Mitchell/ Mary Whittow

+44 (0)20 3727 1000

brett.pollard@fticonsulting.com/victoria.fostermitchell@fticonsulting.com/ Mary.whittow@fticonsulting.com 

 

FTI Consulting (France)

Arnaud de Cheffontaines / Astrid Villette

+33 (0)147 03 69 47 / +33 (0)147 03 69 51

arnaud.decheffontaines@fticonsulting.com / astrid.villette@fticonsulting.com

 

About Novacyt Group

The Novacyt Group is an international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialisation, contract design and manufacturing. The Company's lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high quality assays and reagents worldwide. The Group directly serves oncology, microbiology, haematology and serology markets as do its global partners, which include major corporates.

 

For more information please refer to the website: www.novacyt.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPEAAPAEEENEFF
Date   Source Headline
1st Mar 202412:30 pmRNSLiquidity Agreement and Total Voting Rights
6th Feb 20247:00 amRNSUpdate on Taiwanese divestment
1st Feb 20241:00 pmRNSLiquidity Agreement and Total Voting Rights
25th Jan 20247:00 amRNSTrading update
3rd Jan 202411:00 amRNSLiquidity Agreement and Total Voting Rights
2nd Jan 20247:00 amRNSAppointment of CFO
21st Dec 20237:00 amRNSUpdate on Taiwan laboratory disposal
1st Dec 202311:45 amRNSLiquidity Agreement and Total Voting Rights
7th Nov 20237:00 amRNSIVDR certification for DPYD genotyping assay
1st Nov 20232:30 pmRNSLiquidity Agreement and Total Voting Rights
26th Oct 20233:20 pmRNSResult of AGM
11th Oct 20237:00 amRNSAGM voting
5th Oct 20232:15 pmRNSNotice of rescheduled AGM
2nd Oct 20231:30 pmRNSLiquidity Agreement and Total Voting Rights
28th Sep 20233:15 pmRNSReminder to shareholders re. AGM voting
28th Sep 20237:00 amRNS2023 Interim Results
14th Sep 20237:00 amRNSAGM voting
13th Sep 20237:00 amRNSNotice of Results
11th Sep 20237:55 amRNSCancellation of trading of Yourgene Shares
8th Sep 202312:00 pmRNSCompletion of acquisition of Yourgene Health plc
8th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
7th Sep 202312:22 pmRNSCourt sanction of the Scheme of Arrangement
1st Sep 202312:30 pmRNSLiquidity Agreement and Total Voting Rights
29th Aug 20237:00 amRNSNotice of rescheduled AGM
17th Aug 20235:16 pmRNSAcquisition update
1st Aug 202311:45 amRNSLiquidity Agreement and Total Voting Rights
27th Jul 20237:00 amRNSHalf Year Trading Update
19th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
18th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
17th Jul 202312:00 pmRNSForm 8.5 (EPT/RI)
14th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
13th Jul 20237:00 amRNSNotice of cancelled AGM
12th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
11th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
10th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
7th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
6th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
5th Jul 20231:27 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc Amended
5th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
4th Jul 202312:00 pmRNSForm 8.5 (EPT/RI) - Yourgene Health plc
3rd Jul 202312:00 pmRNSLiquidity Agreement and Total Voting Rights
3rd Jul 20237:01 amRNSRecommended cash offer for Yourgene Health plc
15th Jun 20234:00 pmRNSNotice of rescheduled AGM
12th Jun 20237:00 amRNSReminder to shareholders re. AGM voting
1st Jun 20231:00 pmRNSLiquidity Agreement and Total Voting Rights
26th May 20237:00 amRNSPublication of Annual Report and AGM voting
10th May 20237:00 amRNSNotice of AGM
2nd May 202312:30 pmRNSTotal Voting Rights
27th Apr 20237:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.